BIO, PhRMA press FDA for concrete details on new IT strategy
After the FDA unveiled its overarching IT strategy earlier this fall, lobbying groups like BIO and PhRMA, as well as tech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
